What incremental costs are associated with head and neck cancer (HNCa), and how do they compare with the costs associated with other common cancers?
PET-Directed Management of Node-Positive Head and Neck Cancers
Is neck dissection required routinely in the management of node-positive head and neck squamous cancer after definitive radiation therapy or chemoradiation therapy?
Changing Trends in Laryngeal Cancer and High-Volume Providers
What are the contemporary patterns of laryngeal cancer surgical care and the effect of volume status on surgical care and short-term outcomes?
Managing End-of-Life Care for Patients with Advanced Otolaryngic Cancers
Understanding pre-existing attitudes of patients and their caregivers regarding quality of life versus quantity of life may help otolaryngologists determine how to better use healthcare resources for end-of-life care.
COSM14: HPV Status and Prognosis for Oropharyngeal Cancers
Experts share insights on HPV risk factors, effectiveness of vaccinations, treatment
PET/CT Useful for Head and Neck Cancers, with Limitations
How does combined positron emission tomography and computed tomography (PET/CT) compare with CT and magnetic resonance imaging (MRI) for monitoring head and neck cancer?
Transoral Robotic Surgery Newest Treatment Option for Oropharyngeal Cancers
How to Handle an Otolaryngology Patient Who Declines Treatment
Should a physician try to convince a patient to consider potentially definitive therapy?
Tumor Biomarkers Can Help Predict Outcomes in Larynx Cancer
Are larynx cancer tumor genetic biomarkers predictive of outcome?
Further Research Needed for HPV-Related Cancer Surveillance
Otolaryngologists say more information is needed to assess utility of post-treatment PET/CT scans for patients with HPV-related cancer
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 10
- Next Page »